Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2012, Article ID 931902, 12 pages
http://dx.doi.org/10.1155/2012/931902
Clinical Study

Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson’s Disease: A Pilot Clinical Study

1Advanced Neuro Science Institute, BGS Global Hospital, Bangalore 560060, India
2ANSA Research Foundation, Indiranagar, Bangalore 560038, India

Received 31 August 2011; Accepted 1 November 2011

Academic Editor: Francesco Dazzi

Copyright © 2012 N. K. Venkataramana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Parkinson, “An essay on the shaking palsy,” The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 14, no. 2, pp. 223–222, 2002. View at Google Scholar · View at Scopus
  2. D. J. Moore, A. B. West, V. L. Dawson, and T. M. Dawson, “Molecular pathophysiology of Parkinson's disease,” Annual Review of Neuroscience, vol. 28, pp. 57–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. U. H. O von Bohlen und Halbach, A. Schober, and K. Krieglstein, “Genes, proteins, and neurotoxins involved in Parkinson's disease,” Progress in Neurobiology, vol. 73, no. 3, pp. 151–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. H. Adler, “Nonmotor complications in Parkinson's disease,” Movement Disorders, vol. 20, supplement 11, pp. S23–S29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Braak, E. Ghebremedhin, U. Rüb, H. Bratzke, and K. Del Tredici, “Stages in the development of Parkinson's disease-related pathology,” Cell and Tissue Research, vol. 318, no. 1, pp. 121–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. Palmer, A. C. Granholm, C. G. van Horne et al., “Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats,” Brain Research, vol. 890, no. 1, pp. 86–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Lindvall, “Stem cells for cell therapy in Parkinson's disease,” Pharmacological Research, vol. 47, no. 4, pp. 279–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. C. R. Freed, P. E. Greene, R. E. Breeze et al., “Transplantation of embryonic dopamine neurons for severe Parkinson's disease,” The New England Journal of Medicine, vol. 344, no. 10, pp. 710–719, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. C. W. Olanow, C. G. Goetz, J. H. Kordower et al., “A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease,” Annals of Neurology, vol. 28, no. 3, pp. 57–87, 2003. View at Google Scholar
  10. C. W. Olanow, C. G. Goetz, J. H. Kordower et al., “A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease,” Annals of Neurology, vol. 54, no. 3, pp. 403–414, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Isacson, L. M. Bjorklund, and J. M. Schumacher, “Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells,” Annals of Neurology, vol. 53, supplement 3, pp. S146–S148, 2003. View at Google Scholar
  12. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Woodbury, E. J. Schwarz, D. J. Prockop, and I. B. Black, “Adult rat and human bone marrow stromal cells differentiate into neurons,” Journal of Neuroscience Research, vol. 61, no. 4, pp. 364–370, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Datta, S. Mishra, L. Mohanty, S. Pulikkot, and P. G. Joshi, “Neuronal plasticity of human Wharton's jelly mesenchyma l stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells,” Cytotherapy, vol. 13, no. 8, pp. 918–932, 2011. View at Google Scholar
  15. L. Cova, M. T. Armentero, E. Zennaro et al., “Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease,” Brain Res, vol. 22, no. 1311, pp. 12–27, 2010. View at Google Scholar
  16. S. J. Baek, S. K. Kang, and J. C. Ra, “In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors,” Experimental and Molecular Medicine, vol. 43, no. 10, pp. 596–603, 2011. View at Publisher · View at Google Scholar
  17. E. J. Hannoush, Z. C. Sifri, I. O. Elhassan et al., “Impact of enhanced mobilization of bone marrow derived cells to site of injury,” Journal of Trauma, vol. 71, no. 2, pp. 283–291, 2011. View at Publisher · View at Google Scholar
  18. R. Pal, C. Gopinath, N. M. Rao et al., “Functiona l recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury,” Cytotherapy, vol. 12, no. 6, pp. 792–806, 2010. View at Google Scholar
  19. N. K. Venkataramana, S. K. Kumar, S. Balaraju et al., “Open-labeled study of unilateral autologous bone-marrowderived mesenchymal stem cell transplantation in Parkinson's disease,” Translational Research, vol. 155, no. 2, pp. 62–70, 2010. View at Google Scholar
  20. R. Pal, M. Hanwate, M. Jan, and S. Totey, “Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells,” Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 3, pp. 163–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Cova, M. T. Armentero, E. Zennaro et al., “Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental mode l of Parkinson's disease,” Brain Research, vol. 22, no. 1311, pp. 12–27, 2010. View at Google Scholar
  22. K. Mareschi, M. Novara, D. Rustiche lli et al., “Neural differentiation of human mesenchymal stem cells Evidence for expression of neural markers and eag K+ channel types,” Experimental Hematology, vol. 34, no. 11, pp. 1563–1572, 2006. View at Google Scholar
  23. M. Nayan, A. Paul, G. Chen, R. C. Chiu, S. Prakash, and D. Shum-Tim, “Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardia l delivery in aged recipients with acute myocardia l infarction: in vitro and in vivo investigation,” Journal of Tissue Engineering, vol. 2011, Article ID 741213, 2011. View at Publisher · View at Google Scholar
  24. H. J. Park, P. H. Lee, O. Y. Bang, G. Lee, and Y. H. Ahn, “Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease,” Journal of Neurochemistry, vol. 107, no. 1, pp. 141–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Blandini, L. Cova, M. T. Armentero et al., “Cell Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat,” Transplant, vol. 19, no. 2, pp. 203–217, 2010. View at Google Scholar
  26. Y. X. Chao, B. P. He, and S. S. Tay, “Mesenchymal stem cell transplantation attenuates blood bra in barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxic ity in the substantia nigra in a model of Parkinson's disease,” Journal of Neuroimmunology, vol. 216, no. 1-2, pp. 39–50, 2009. View at Google Scholar
  27. T. Nagatsu, M. Mogi, H. Ichinose, and A. Togari, “Cytokines in Parkinson's disease,” Journal of Neural Transmission, no. 58, pp. 143–151, 2000. View at Google Scholar · View at Scopus
  28. R. K. Stumm, J. Rummel, V. Junker et al., “A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-se lective regulation of SDF-1 expression modulates CXCR4-dependent neurona l plastic ity and cerebral leukocyte recruitment after focal ischemia,” The Journal of Neuroscience, vol. 22, no. 14, pp. 5865–5878, 2002. View at Google Scholar